KUALA LUMPUR: The Health Ministry has approved CanSino’s single-dose Convidecia vaccine to be used as a heterologous booster with all Covid-19 primary vaccines in Malaysia.
Solution Group Bhd (SGB), the Asean manufacturing partner of CanSino Biologics Inc in a statement, said the vaccine was approved for adults aged 18 years and above, regardless of the type of vaccine they received during their earlier Covid-19 vaccination.
Already a subscriber? Log in
5.5 PAYDAY OFFER: 35% OFF Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
